| Pharmaceutical active ingredients: |
| Fluticasone PropionateSalmeterol Xinafoate |
| Available forms, composition and doses of Advair HFA: |
| Aerosol, Metered; Inhalation; Fluticasone Propionate 0.045 mg; Salmeterol Xinafoate 0.021 mg / doseAerosol, Metered; Inhalation; Fluticasone Propionate 0.115 mg; Salmeterol Xinafoate 0.021 mg / doseAerosol, Metered; Inhalation; Fluticasone Propionate 0.23 mg; Salmeterol Xinafoate 0.021 mg / dose |
| Advair HFA medical category: |
| Human:Antiasthmatic and COPD preparationsOrally inhaled preparationsSelective beta-2-adrenergic agonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01AD08 - FluticasoneR03AK06 - Salmeterol and other drugs for obstructive airway diseasesR03BA05 - Fluticasone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKline |
| Related documents and information about Advair HFA: |
| Advair Diskus prescribing information (PDF)Advair Diskus medication guide (PDF)Advair HFA prescribing information (PDF)Advair HFA medication guide (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Seroflo Inhaler | Fluticasone Propionate; Salmeterol | Cipla |
| Seroflo Multihaler | Fluticasone Propionate; Salmeterol | Cipla |
| Seroflo Rotacaps | Fluticasone Propionate; Salmeterol | Cipla |
| Advair | Fluticasone Propionate; Salmeterol Xinafoate | GlaxoSmithKline |
| Advair Diskus | Fluticasone Propionate; Salmeterol Xinafoate | GlaxoSmithKline |
| Aerometrol Plus | Fluticasone Propionate; Salmeterol Xinafoate | Andromaco Laboratorios |
| Aliflus | Fluticasone Propionate; Salmeterol Xinafoate | Menarini |
| Anasma | Fluticasone Propionate; Salmeterol Xinafoate | Alter |
| Atmadisc | Fluticasone Propionate; Salmeterol Xinafoate | Sanol; Schwarz Pharma |
| Atmadisc Diskus | Fluticasone Propionate; Salmeterol Xinafoate | Sanol; Schwarz Pharma |